☆ 4.6 Editorial Material

Limited Impact of Anti-PD-1/PD-L1 Monotherapy for Hepatocellular Carcinoma

LIVER CANCER (2020)

Get Full Text
Add to Collection

Journal

LIVER CANCER
Volume 9, Issue 6, Pages 629-639

Publisher

KARGER
DOI: 10.1159/000512170

Keywords

Immune checkpoint inhibitors; Atezolizumab; Bevacizumab; Combination immunotherapy

Categories

Oncology Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.